BioSpace News Archive

Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced that it will report the first quarter 2020 on Wednesday, May 6, 2020, after the close of the US market

Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2020 third quarter ended March 31, 2020 on Tuesday, May 12, 2020 after the close of the stock market.

Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2020 first quarter financial results on Monday, May 11, 2020, before the market opens.

Align Technology, Inc. (NASDAQ: ALGN) today announced that 2 million teen patients have now started treatment with the Invisalign system – the most advanced clear aligner system and leading digital approach to orthodontic treatment.

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) today announced the election of the eleven directors nominated at its 2020 annual meeting of shareholders held on April 28, 2020.

Synergy CHC Corp. (OTCQB: SNYR) (“Synergy” or the “Company”), a consumer health care & beauty company, today reported results for the fiscal year ended December 31, 2019.

REFINE USA, LLC, a leader in cosmetic medical aesthetic devices since 2006, has been granted a class II medical clearance from the FDA for its medical grade Microneedling device, Rejuvapen NXT

The Simón Bolívar Foundation Inc., the non-profit, private foundation of CITGO Petroleum Corporation, is awarding up to $200,000 to five non-profit organizations working in health-focused initiatives for vulnerable Venezuelans as part of its COVID-19 Small Grants Program.

Abiomed (NASDAQ: ABMD), maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal membrane oxygenation (ECMO) system that will complement and expand Abiomed’s product portfolio to more comprehensively serve the needs of patients whose lungs can no longer provide sufficient oxygenation,

Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”), a consumer packaged goods company in the cannabis products market, today released its fourth quarter and full year 2019 financial results.